Neuroone Medical Technologies (NMTC) Total Liabilities (2010 - 2026)

Neuroone Medical Technologies has disclosed Total Liabilities across 17 years of filings, most recently posting $2.5 million for Q1 2026.

• Quarterly Total Liabilities fell 25.2% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 25.2% YoY) and the FY2025 annual result came in at $3.7 million, down 18.36% from the prior year.
• Total Liabilities climbed to $2.5 million in Q1 2026, from $2.2 million in the prior quarter.
• Across five years, Total Liabilities topped out at $4.5 million in Q3 2024 and bottomed at $952478.0 in Q2 2022.
• The 5-year median for Total Liabilities is $1.9 million (2024), against an average of $2.3 million.
• Year-over-year, Total Liabilities tumbled 42.58% in 2023 and soared 153.46% in 2024.
• Neuroone Medical Technologies' Total Liabilities stood at $1.5 million in 2022, then retreated by 5.66% to $1.4 million in 2023, then soared by 153.46% to $3.6 million in 2024, then plunged by 38.87% to $2.2 million in 2025, then advanced by 14.51% to $2.5 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $2.5 million, $2.2 million, and $3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.